InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Demopulos Gregory A MD, 董事长兼首席执行官. Officer active across 2 companies, notably OMEROS CORP. In total, 7 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. Activity tracked since 19 May 2021. The latest transaction was filed on 18 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Demopulos Gregory A MD is Chairman, CEO, and President at OMEROS CORP. He is responsible for the strategic direction of the company, which specializes in developing treatments for rare diseases. His leadership is essential in guiding growth and innovation within OMEROS.